CSE CEO: Psychedelics Investing is a Pharma Play | Summary and Q&A

344 views
August 11, 2020
by
Investing News
YouTube video player
CSE CEO: Psychedelics Investing is a Pharma Play

TL;DR

The Canadian Securities Exchange (CSE) has extended its support from the cannabis industry to companies involved in the psychedelic space, helping them raise growth capital in the public equity markets.

Install to Summarize YouTube Videos and Get Transcripts

Questions & Answers

Q: What has been the CSE's involvement with the cannabis industry?

The CSE has supported the cannabis industry in Canada, the United States, and globally, with a significant percentage of its issuers and market capitalization being in the cannabis space.

Q: How did companies in the psychedelic space face similar challenges to early cannabis companies?

Companies in the psychedelic space also struggled to attract investment from conventional sources and turned to the public equity markets, seeking growth capital. They faced regulatory and disclosure issues similar to those of cannabis companies.

Q: What are the differences between the cannabis and psychedelics markets in terms of investment opportunities?

The cannabis market is a consumer package goods opportunity with a known addressable market. Psychedelics, on the other hand, are more focused on pharmaceutical applications and require extensive research, clinical trials, and FDA approvals.

Q: What signs indicate that the psychedelic sector is heading in the right direction for investment opportunities?

Some early research companies in the psychedelics space have received fast track approvals from the FDA to advance to the next phase of clinical trials. This indicates promising preliminary results and the potential for these compounds to become mainstream treatments.

Summary & Key Takeaways

  • The CSE has been involved in supporting the cannabis industry in Canada, the United States, and globally.

  • Companies in the psychedelic space faced similar challenges to early cannabis companies and turned to public equity markets for growth capital.

  • The CSE provided guidance to these companies on disclosure issues and helped them navigate the regulatory landscape.

Share This Summary 📚

Summarize YouTube Videos and Get Video Transcripts with 1-Click

Download browser extensions on:

Explore More Summaries from Investing News 📚

Summarize YouTube Videos and Get Video Transcripts with 1-Click

Download browser extensions on: